ES553013A0 - Un procedimiento para preparar sales o esteres farmaceuticamente aceptables de 3'-azido-3'-dexositimidina. - Google Patents

Un procedimiento para preparar sales o esteres farmaceuticamente aceptables de 3'-azido-3'-dexositimidina.

Info

Publication number
ES553013A0
ES553013A0 ES553013A ES553013A ES553013A0 ES 553013 A0 ES553013 A0 ES 553013A0 ES 553013 A ES553013 A ES 553013A ES 553013 A ES553013 A ES 553013A ES 553013 A0 ES553013 A0 ES 553013A0
Authority
ES
Spain
Prior art keywords
dexositimidine
azido
esters
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES553013A
Other languages
English (en)
Other versions
ES8800257A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506869A external-priority patent/GB8506869D0/en
Priority claimed from GB858511774A external-priority patent/GB8511774D0/en
Priority claimed from GB858523881A external-priority patent/GB8523881D0/en
Priority claimed from GB868603450A external-priority patent/GB8603450D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES8800257A1 publication Critical patent/ES8800257A1/es
Publication of ES553013A0 publication Critical patent/ES553013A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES553013A 1985-03-16 1986-03-14 Un procedimiento para preparar sales o esteres farmaceuticamente aceptables de 3'-azido-3'-dexositimidina. Expired ES8800257A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB858506869A GB8506869D0 (en) 1985-03-16 1985-03-16 Antiviral compound
GB858511774A GB8511774D0 (en) 1985-05-09 1985-05-09 Antiviral compounds
GB858523881A GB8523881D0 (en) 1985-09-27 1985-09-27 Antiviral compounds
GB868603450A GB8603450D0 (en) 1986-02-12 1986-02-12 Antiviral compounds

Publications (2)

Publication Number Publication Date
ES8800257A1 ES8800257A1 (es) 1987-11-01
ES553013A0 true ES553013A0 (es) 1987-11-01

Family

ID=27449646

Family Applications (2)

Application Number Title Priority Date Filing Date
ES553013A Expired ES8800257A1 (es) 1985-03-16 1986-03-14 Un procedimiento para preparar sales o esteres farmaceuticamente aceptables de 3'-azido-3'-dexositimidina.
ES557209A Expired ES8802469A1 (es) 1985-03-16 1986-11-18 Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557209A Expired ES8802469A1 (es) 1985-03-16 1986-11-18 Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.

Country Status (5)

Country Link
KR (1) KR860006987A (es)
AU (2) AU587739B2 (es)
ES (2) ES8800257A1 (es)
HU (2) HU197209B (es)
PH (1) PH27190A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE73219B1 (en) * 1985-03-16 1997-05-07 Wellcome Found Therapeutic nucleosides
US4852127A (en) * 1985-03-22 1989-07-25 American Telephone And Telegraph Company, At&T Bell Laboratories Universal protocol data receiver

Also Published As

Publication number Publication date
HU199501B (en) 1990-02-28
AU587739B2 (en) 1989-08-24
AU1215988A (en) 1988-06-23
HUT40570A (en) 1987-01-28
ES8800257A1 (es) 1987-11-01
ES8802469A1 (es) 1988-07-16
PH27190A (en) 1993-04-16
ES557209A0 (es) 1988-07-16
KR860006987A (ko) 1986-10-06
HU197209B (en) 1989-03-28
AU574620B1 (en) 1988-07-07

Similar Documents

Publication Publication Date Title
ES533821A0 (es) Procedimiento para preparar n2-acil-9-(1, 3-dihidroxi-2-propoximetil)-guaninas y sus sales farmaceuticamente aceptables
ES551538A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidro-4-oxonaftiridina y sus sales
ES554405A0 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES547621A0 (es) Procedimiento para la preparacion de un medio de suministro de drogas
ES552189A0 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
ES553529A0 (es) Un procedimiento para preparar derivados de 4'-desmetil-4-epipodofilotoxina
ES553415A0 (es) Un procedimiento para la preparacion de derivados de ariletanolamina.
ES512969A0 (es) "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
ES515191A0 (es) "un procedimiento para la preparacion de sales de s-adenosilmetionina".
ES552032A0 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
ES547717A0 (es) Procedimiento para preparar sales de ciclimonio
ES550889A0 (es) Un procedimiento para la preparacion de sales policiclicas
ES557659A0 (es) Un procedimiento para preparar derivados de ciclopentil-eter.
ES551603A0 (es) Un procedimiento para la preparacion de sales organicas de acidos fosfonicos.
ES550439A0 (es) Un procedimiento para la preparacion de sales de acidos policarboxilicos.
ES552772A0 (es) Un procedimiento para producir 2,3,4-tri-o-acil-d- y-o l-hexosas
ES510913A0 (es) "un procedimiento para la preparacion de derivados de piridina".
ES553013A0 (es) Un procedimiento para preparar sales o esteres farmaceuticamente aceptables de 3'-azido-3'-dexositimidina.
ES551866A0 (es) Procedimiento de preparacion de nuevos derivados alquilamino-furanonas y de sales y diastereoisomeros farmaceuticamente aceptables de los mismos.
ES549472A0 (es) Un procedimiento para preparar 1-beta-d-ribofuranosil-1,2,4-triazol-3-carboxamida.
AR240822A1 (es) Un procedimiento para la preparacion de una trans-octahidro-oxazolo|4,5-g¨quinolina y sus sales
ES557636A0 (es) Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-benzoxapina
ES511527A0 (es) "un procedimiento para la preparacion de sales de fosfomicina".
ES557045A0 (es) Un procedimiento para preparar (1,2,4-oxadiazol-3-il)-arilmetanonas
ES557625A0 (es) Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070806